Bank of New York Mellon Corp
BankPosition in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1390777
NEW YORK, NY
Position in ARCT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$539,707
-$39,268 QoQ
Shares Held
80,314
+7.1% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 133 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ARCT ranks #235 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ARCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $539,707 | 80,314 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $578,975 | 74,997 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $467,724 | 76,301 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,634,167 | 88,669 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,104,287 | 84,880 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $793,496 | 74,929 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,326,713 | 78,180 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $2,325,733 | 100,204 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,902,056 | 119,181 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,903,910 | 115,603 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $4,190,934 | 132,919 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $2,412,609 | 94,427 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $2,605,290 | 90,840 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $1,805,922 | 75,341 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,298,829 | 76,582 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,120,331 | 75,596 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,084,248 | 68,885 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,096,677 | 77,770 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,888,185 | 78,038 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,668,405 | 76,777 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,394,822 | 70,769 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,047,320 | 73,785 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,523,018 | 81,213 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,693,647 | 62,789 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,472,171 | 52,892 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||